It's regrettable the BMA has decided to proceed with further unnecessary industrial action.
Trial sponsors are often disinclined to proceed with further study in the absence of this additional efficacy evidence.
But the eruv is still in place, and the town has not decided whether to proceed with further action to have it removed.
So having spoken to its shareholders representing more than 50% of the company, it decided not to proceed with further discussions.
ICAS grew out of a strong interest expressed by the participants to proceed with further evaluations after completion of the earlier FALSIRE II project.
"The program can work, but it lacks sufficient resources to proceed with further litigation," said Bonnie Chaiken, deputy bureau chief of the county attorney's municipal and environmental litigation unit.
However, Arkansas will struggle to proceed with further killings because its batch of midazolam, the sedative used in the first of its three lethal injections, runs out this weekend and drug companies refuse to provide new supplies.
A legal fight over the placing of Orthodox Jewish boundary markers on public property seemingly came to a close today when the United States Supreme Court declined to hear the case, but the mayor here said that the town still had not decided whether to proceed with further action to have the markers removed.
A spokesperson for the department of jobs and small business said that of the complaints listed in the document: three investigations were ongoing; 28 cases were "unsubstantiated or had insufficient evidence to proceed with further action"; and one matter concerning allegations of fraud "was substantiated and payment recovery was undertaken".
Data developed in this study are expected to be useful to pavement designers and site engineers in the field implementation of the stabilization scheme such as when to open the stabilized layer to construction traffic or when to proceed with further construction works.
This article provides summaries from the panel discussion as well as personal perspectives of the panelists on how to proceed with further clinical testing of ERAs and guidance for researchers and decision makers in clinical drug development on where future research efforts might best be focused.
